Poland· PL-100322781
Bemfola
A follitropin alfa product containing follitropinum alfa, registered in Poland by Gedeon Richter Plc.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Follitropin alfa is registered in 12 of 19 countries.
Countries holding a registration under ATC G03GA05 (follitropin alfa), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Follitropin alfa · ATC G03GA05
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
URPL (Poland)- Active substance
- Follitropinum alfa
- Manufacturer
- Gedeon Richter Plc.
- Country
- Poland (PL)
- ATC code
- G03GA05
- ATC class
- Follitropin alfa
- Defined daily dose
- 75 E, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin07640165220207
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Follitropin alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBemfola 150units/0.25ml solution for injection pre-filled pensGedeon Richter (UK) Ltd
- CzechiaBEMFOLAGedeon Richter Plc., Budapešť
- SpainBEMFOLA 150 UI/0,25 ml solucion inyectable en pluma precargadaGedeon Richter Plc.
- FinlandBemfolaGedeon Richter Plc
- BelgiumBemfola 150 IU/0.25 mlGedeon Richter
- ItalyBEMFOLA*1 cartuccia in penna preriempita SC 150 UI/0,25 ml + agoGEDEON RICHTER PLC
- SwedenBemfola 150 IE/0,25 ml Injektionsvätska, lösning i förfylld injektionspennaGedeon Richter Plc
- NetherlandsBemfola 150 IE/0,25 ml oplossing voor injectie in een voorgevulde penGedeon Richter Plc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bemfola, Gonal-F
- Liechtenstein · Bemfola, Gonal-F
- Norway · Bemfola, Gonal-F
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e0fddac9-ac2b-4b26-80fd-2f7e7aeecbfd GET /v1/drugs/e0fddac9-ac2b-4b26-80fd-2f7e7aeecbfd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "450 j.m./0,75 ml",
"packaging": "07640165220207 ¦ Rpz ¦ EU/1/13/909/005 ¦ 102891\n1 wstrzykiwacz 0,75 ml\nRpz ¦ EU/1/13/909/014 ¦ 119306\n5 wstrzykiwaczy 0,75 ml\nRpz ¦ EU/1/13/909/015 ¦ 119307\n10 wstrzykiwaczy 0,75 ml",
"substance": "Follitropinum alfa 450 j.m.",
"common_name": "Follitropinum alfa",
"pl_product_id": "100322781",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about follitropin alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.